InterCure Ltd. (INCR)
NASDAQ: INCR · IEX Real-Time Price · USD
2.050
+0.020 (0.99%)
At close: Jul 2, 2024, 4:00 PM
2.150
+0.100 (4.88%)
After-hours: Jul 2, 2024, 7:40 PM EDT
InterCure Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for InterCure.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for InterCure.
Recommendation Trends
| Rating | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $10 → $5 | Buy | Maintains | $10 → $5 | +143.90% | Apr 12, 2023 |
| Barclays | Barclays | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Dec 11, 2017 |
| Credit Suisse | Credit Suisse | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 14, 2017 |
| Keybanc | Keybanc | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 13, 2017 |
| Baird | Baird | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 10, 2017 |
Financial Forecast
Revenue This Year
302.19M
from 355.55M
Decreased by -15.01%
Revenue Next Year
461.28M
from 302.19M
Increased by 52.65%
EPS This Year
-0.01
from -1.36
EPS Next Year
0.88
from -0.01
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 311.1M | 474.9M |
| Avg | 302.2M | 461.3M |
| Low | 290.3M | 443.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | -12.5% | 57.1% |
| Avg | -15.0% | 52.6% |
| Low | -18.3% | 46.7% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -0.01 | 0.90 |
| Avg | -0.01 | 0.88 |
| Low | -0.01 | 0.84 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.